A Single Arm, Open-label, Phase II Study to Assess the Efficacy of Rucaparib in Metastatic Breast Cancer Patients With a BRCAness Genomic Signature
Phase of Trial: Phase II
Latest Information Update: 06 Jun 2017
At a glance
- Drugs Rucaparib (Primary)
- Indications Advanced breast cancer
- Focus Proof of concept; Therapeutic Use
- Acronyms RUBY
- 06 Jun 2017 Trial design presented at the 53rd Annual Meeting of the American Society of Clinical Oncology
- 23 May 2017 According to a Clovis Oncology media release, results from this trial will be presented at the 2017 American Society of Clinical Oncology (ASCO) Annual Meeting.
- 24 Oct 2016 Status changed from not yet recruiting to recruiting.